Viewing Study NCT05306132


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2025-12-27 @ 12:02 PM
Study NCT ID: NCT05306132
Status: RECRUITING
Last Update Posted: 2025-12-23
First Post: 2022-03-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of ASKC202 With or Without ASK120067
Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module